Lupin Clobetasol Cream Recall: Failed Content Uniformity
Lupin Pharmaceuticals recalls 0.05% Clobetasol Propionate Cream due to failed content uniformity. This may affect medication strength. Check NDC 68180-956-04 and lot numbers for affected products.
Lower-risk recall
Failed content uniformity specifications.
What happened, in plain English
Lupin Pharmaceuticals is recalling a specific strength of prescription corticosteroid cream because it failed content uniformity tests. This means the actual medication strength might be inconsistent, which could affect treatment effectiveness. Read more at govinfonow.com/recall/692869-lupin-clobetasol-cream-recall-failed-content-uniformity.
Source Summary by GovInfoNow · govinfonow.com/recall/692869-lupin-clobetasol-cream-recall-failed-content-uniformity · Updated September 14, 2026 · FDA enforcement record: FDA #D-0789-2026
Cite this page
“Lupin Clobetasol Cream Recall: Failed Content Uniformity.” GovInfoNow, updated September 14, 2026. https://govinfonow.com/recall/692869-lupin-clobetasol-cream-recall-failed-content-uniformity. Based on FDA recall #D-0789-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0789-2026%22&limit=1).
Why it’s dangerous
The product failed content uniformity tests, meaning the actual amount of active medication may vary. This inconsistency could lead to inconsistent treatment effects, but does not pose an immediate safety risk like injury or death.
Who’s affected
Prescription users of the 0.05% Clobetasol Propionate Cream 60g tube. People with skin conditions requiring this medication are most at risk.
How to tell if you have this one
Check for the NDC code 68180-956-04 on the product label. The lot numbers KB00427 (expiring 4/30/2028) and KA00308 (expiring 10/31/2026) are also associated with this recall.
- Brand
Lupin Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Label
Look for the NDC code 68180-956-04 and lot numbers KB00427 or KA00308 on the cream tube.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 30 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Lupin Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0789-2026 (August 3, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0789-2026 to see it in context.
- Plain-language summary written by qwen3:4b on September 14, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.